In the largest settlement of its kind, Teva Pharmaceuticals agreed to pay $425 million to resolve allegations the company and a related business paid kickbacks to charitable foundations in order ...

Teva agreed to pay $450 million to resolve kickback allegations related to Copaxone and generic drug price-fixing schemes. Since 2017, over $1 billion has been collected from companies accused of ...

Data from a new randomized, placebo-controlled trial have demonstrated the efficacy of budesonide in inducing remission of this disease; this study is an important contribution to this field.

The best deals are not always the quickest to close, as Teva Pharmaceuticals learned in 2016 after its much-lauded acquisition of Allergan’s generic business, Actavis Generics. In its acquisition of ...

An albuterol/budesonide fixed-dose combination rescue medication has been shown to reduce severe exacerbations in patients with asthma for the first time, according to positive Phase 3 trial ...

Budesonide 160mcg, glycopyrrolate 9mcg, formoterol fumarate 4.8mcg; per inhalation; metered-dose inhaler with dose counter. is supplied as a pressurized aluminum canister with an attached dose ...

Teva Pharmaceuticals TEVA-0.33%decrease; red down pointing triangle will pay $450 million to resolve allegations that the generic drug manufacturer submitted false claims and violated a federal ...

As of 12:18 PM EDT. Market Open. Amicus stock gains on reaching a licensing deal with Teva, which ends their Galafold patent lawsuit. Amicus Therapeutics (FOLD) witnessed a jump in share price ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International ...